Kilobaser vs Yoneda Labs

Side-by-side comparison of AI visibility scores, market position, and capabilities

Yoneda Labs leads in AI visibility (36 vs 33)

Kilobaser

EmergingHealthcare

General

Vienna Austria YC W21 desktop DNA synthesizer enabling on-demand oligo production in research labs at $3.1M revenue 2024; $1.99M BioTools Innovator-backed "Nespresso for DNA" at $35.5-49.5K competing with IDT and Evonetix for benchtop DNA synthesis.

AI VisibilityBeta
Overall Score
D33
Category Rank
#423 of 1167
AI Consensus
75%
Trend
stable
Per Platform
ChatGPT
33
Perplexity
39
Gemini
41

About

Kilobaser is a Vienna, Austria-based biotechnology hardware company — backed by Y Combinator (W21) with $1.99 million in total funding from BioTools Innovator — providing research laboratories and life sciences companies with desktop DNA and RNA oligonucleotide synthesizers that enable individual scientists to produce custom synthetic DNA sequences directly on their benchtops without sending samples to commercial synthesis services, generating $3.1 million in annual revenue in 2024 with consistent revenue growth since the 2014 company founding. Positioned as the "Nespresso Machine for DNA," Kilobaser offers the Basic Edition synthesizer ($35,500) and Extended Edition ($49,500) — compact, affordable instruments that democratize access to on-demand DNA synthesis for research labs that need rapid turnaround on custom oligonucleotide sequences for PCR primers, CRISPR guides, sequencing adapters, and synthetic gene construction.

Full profile

Yoneda Labs

EmergingHealthcare

General

AI chemical reaction optimization with 95% accuracy for drug discovery synthesis parameters; $4.5M from Khosla Ventures and YC competing to automate pharmaceutical process chemistry development.

AI VisibilityBeta
Overall Score
D36
Category Rank
#999 of 1167
AI Consensus
53%
Trend
stable
Per Platform
ChatGPT
44
Perplexity
32
Gemini
30

About

Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists with AI systems that determine optimal reaction parameters (temperature, solvent, catalyst, concentration) for new chemical synthesis routes, achieving 95% accuracy in suggesting effective conditions for small-scale trials. Founded in 2023 and backed by Khosla Ventures, 468 Capital, 500 Global, and Y Combinator with $4.5 million raised including a $4 million seed round in April 2024, Yoneda Labs brings mathematical category theory foundations (the name references Yoneda's lemma in category theory) to chemistry AI.

Full profile

AI Visibility Head-to-Head

33
Overall Score
36
#423
Category Rank
#999
75
AI Consensus
53
stable
Trend
stable
33
ChatGPT
44
39
Perplexity
32
41
Gemini
30
31
Claude
47
36
Grok
33

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.